Kymera Therapeutics, Inc. · NASDAQ:KYMR

Booth Bruce sold 285,684 Kymera Therapeutics, Inc. shares (Form 4)

Traded Jun 25, 2026 · Filed Jun 25, 2026

On Jun 25, 2026, Booth Bruce (Director) sold 285,684 Kymera Therapeutics, Inc. shares at an average US$121.86 for US$34.8M under a trading plan, leaving 529,718 shares. Filed Jun 25, 2026 (Form 4).

Sold
285,684 shares
Price
US$121.86 average (US$119.71 to US$129.61)
Value
US$34.8M
Holding after
529,718 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 25, 2026Common StockSale37,179US$119.713,075,906Indirect
Jun 25, 2026Common StockSale112,299US$120.662,963,607Indirect
Jun 25, 2026Common StockSale40,774US$121.382,922,833Indirect
Jun 25, 2026Common StockSale4,977US$122.672,917,856Indirect
Jun 25, 2026Common StockSale10,860US$123.622,906,996Indirect
Jun 25, 2026Common StockSale11,711US$124.612,895,285Indirect
Jun 25, 2026Common StockSale3,716US$125.822,891,569Indirect
Jun 25, 2026Common StockSale1,609US$126.712,889,960Indirect
Jun 25, 2026Common StockSale25,075US$127.372,864,885Indirect
Jun 25, 2026Common StockSale2,197US$128.692,862,688Indirect
Jun 25, 2026Common StockSale337US$129.612,862,351Indirect
Jun 25, 2026Common StockSale5,144US$119.71559,524Indirect
Jun 25, 2026Common StockSale15,660US$120.66543,864Indirect
Jun 25, 2026Common StockSale5,689US$121.38538,175Indirect
Jun 25, 2026Common StockSale698US$122.67537,477Indirect
Jun 25, 2026Common StockSale1,517US$123.62535,960Indirect
Jun 25, 2026Common StockSale1,639US$124.61534,321Indirect
Jun 25, 2026Common StockSale522US$125.82533,799Indirect
Jun 25, 2026Common StockSale223US$126.71533,576Indirect
Jun 25, 2026Common StockSale3,507US$127.37530,069Indirect
Jun 25, 2026Common StockSale305US$128.69529,764Indirect
Jun 25, 2026Common StockSale46US$129.61529,718Indirect

Source

View original at SEC

Related